Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

November 08, 2005; 65 (9) Editorials

X-linked oligophrenic vermian dysgenesis

Syndromic vs non-syndromic X-linked mental retardation?

Joseph J. Higgins, Haluk Topaloglu
First published November 7, 2005, DOI: https://doi.org/10.1212/01.wnl.0000187915.51781.b8
Joseph J. Higgins
From the Center for Human Genetics and Child Neurology (Dr. Higgins), Mid-Hudson Family Health Institute, New Paltz, NY; and Department of Pediatric Neurology (Dr. Topaloglu), Hacettepe University, Ankara, Turkey.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haluk Topaloglu
From the Center for Human Genetics and Child Neurology (Dr. Higgins), Mid-Hudson Family Health Institute, New Paltz, NY; and Department of Pediatric Neurology (Dr. Topaloglu), Hacettepe University, Ankara, Turkey.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
X-linked oligophrenic vermian dysgenesis
Syndromic vs non-syndromic X-linked mental retardation?
Joseph J. Higgins, Haluk Topaloglu
Neurology Nov 2005, 65 (9) 1346-1347; DOI: 10.1212/01.wnl.0000187915.51781.b8

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
186

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

X-linked mental retardation (XLMR) has often been divided into syndromic XLMR (S-XLMR) vs non-syndromic XLMR (NS-XLMR) based on the presence or absence of somatic and dysmorphic features. Although mental retardation by definition is the only clinical feature of NS-XLMR, the concept of NS-XLMR as a nosologic entity is losing its identity as new candidate genes for XLMR are discovered. For example, NS-XLMR is caused by mutations in the ARX gene but other mutations within the ARX gene cause additional features: ambiguous genitalia, lissencephaly, infantile spasms, and agenesis of the corpus callosum.1–3 In fragile X syndrome, a frequent cause of S-XLMR, the typical dysmorphic features of the syndrome may not evolve until late childhood or adolescence.4 These broad phenotypes decrease diagnostic certainty and advocate the screening of selected candidate genes for mutations in individuals with NS-XLMR who do not have cytogenetic abnormalities or CGG trinucleotide repeat expansions in the FMR1 gene (Fragile X syndrome). A panel of candidate genes (ARX, DLG3, FACL4, FTSJ1, JARID1C, PQBP1, TM4SF2, and ZNF41) has a mutation detection rate up to 20% to 25% of individuals with NS-XLMR. New testing strategies are on the horizon as the functional aspects of these genes are characterized and newer DNA and protein …

View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • Oligophrenin 1 mutations frequently cause X-linked mental retardation with cerebellar hypoplasia

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Oligophrenin 1 mutations frequently cause X-linked mental retardation with cerebellar hypoplasia
    G. Zanni, Y. Saillour, M. Nagara et al.
    Neurology, October 12, 2005
  • Clinical Implications of Neuroscience Research
    Rho GTPases
    Role in dendrite and axonal growth, mental retardation, and axonal regeneration
    Eduardo E. Benarroch et al.
    Neurology, April 16, 2007
  • Articles
    Distinguishing 3 classes of corpus callosal abnormalities in consanguineous families
    R.M. Hanna, S.E. Marsh, D. Swistun et al.
    Neurology, January 24, 2011
  • Articles
    Bilateral periventricular nodular heterotopia with mental retardation and syndactyly in boys: A new X-linked mental retardation syndrome
    W. B. Dobyns, R. Guerrini, D. K. Czapansky-Beilman et al.
    Neurology, October 01, 1997
Neurology: 100 (14)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise